• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
MPOX
JOIN
Posted on May 19, 2025May 23, 2025

Brighton Collaboration News — May 2025

Brighton Collaboration NewsQuarterly Updates From Our Vaccine Safety CommunityMay 2025Letter from the Science Board - Dr. Robert W...
Read More
Posted on September 9, 2024September 10, 2024

Brighton Collaboration News — Sept 2024

Brighton Collaboration NewsQuarterly Updates From Our Vaccine Safety CommunitySeptember 2024Letter from our Research DirectorThe W...
Read More
Posted on June 20, 2024July 5, 2024

Brighton Collaboration News — June 2024

Brighton Collaboration News Quarterly Updates From Our Vaccine Safety Community June 2024 Letter from our Science Board Chair...
Read More
Posted on April 1, 2024April 1, 2024

VSQ Q1 2024

The 2024 Quarter 1 issue of Brighton Collaboration’s Vaccine Safety Quarterly is available below. Read the Vaccine Safety Qua...
Read More
Posted on January 3, 2024January 4, 2024

VSQ Q4 2023

The Quarter 4 issue of Brighton Collaboration’s Vaccine Safety Quarterly is available below. Read the Vaccine Safety Quarterl...
Read More
Posted on September 28, 2023January 4, 2024

VSQ Q3 2023

The Quarter 3 issue of Brighton Collaboration’s Vaccine Safety Quarterly is available below. VSQ Q3 2023...
Read More
Posted on July 1, 2023November 6, 2023

VSQ – Q2 2023

The Quarter 2 issue of Brighton Collaboration's Vaccine Safety Quarterly is available below. VSQ Q2 2023...
Read More
Posted on May 22, 2023June 20, 2023

VSQ – Q1 2023

The Q1 Spring 2023 issue of the Vaccine Safety Quarterly (VSQ) newsletter is now available here!...
Read More
Posted on January 3, 2023June 20, 2023

VSQ – Q4 2022

The Q4 2022 issue of the Vaccine Safety Quarterly (VSQ) newsletter is now available here!...
Read More
Posted on September 30, 2022June 20, 2023

VSQ – Q3 2022

The Q3 2022 issue of the Vaccine Safety Quarterly (VSQ) newsletter is now available here!...
Read More
1 2 Next page

Recent Posts

  • Standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa feverJune 2, 2025
  • Strengthening Vaccine Safety from Outbreaks to Infants: SPEAC at the World Vaccine CongressMay 27, 2025
  • Brighton Collaboration News — May 2025May 19, 2025
  • Safety by Numbers – February 2025February 19, 2025
  • Brighton Collaboration News — Sept 2024September 9, 2024

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy